QIAGEN GENEREAD

WIPO WIPO 2013

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke QIAGEN GENEREAD wurde als Wortmarke am 12.07.2013 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 02. Oktober 2018

Markenform Wortmarke
Aktenzeichen 1176282
Registernummer 011512894
Länder Schweiz China Japan Russland Vereinigte Staaten von Amerika (USA)
Basismarke EU Nr. 011512894, 21. Juni 2013
Anmeldedatum 12. Juli 2013
Ablaufdatum 12. Juli 2023

Markeninhaber

Qiagen Strasse 1
40724 Hilden
DE

Markenvertreter

Waren und Dienstleistungen

01 Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical reagents, enzymes and buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
05 Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, in particular diagnostics, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, in particular reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
09 Scientific apparatuses, instruments and devices, as well as their parts and components included in this class; software for use in scientific and medical research; scientific apparatuses, instruments and devices, software in the area of analysis of nucleic acids, in particular sequencing of nucleic acids
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
29. Februar 2016 2016/10 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
29. September 2014 2014/40 Gaz CH Ablehnung
24. September 2014 2014/47 Gaz RU Ablehnung
15. September 2014 2014/38 Gaz CN Ablehnung
31. Juli 2014 2014/32 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
22. Mai 2014 2014/21 Gaz JP Ablehnung
01. November 2013 2013/45 Gaz US Ablehnung
12. Juli 2013 2013/38 Gaz EM Eintragung

ID: 141176282